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Risk Factors
Signs & Symptoms Nursing Implications
• Assist with disability at work & home: cool environment, ergonomic seating, 
handicap parking, compensatory techniques: recording, planning, use of smart 
phone apps & reminders, removing distractions, rest, & restorative therapies
• Counsel & advocate for patients & families
• Educate on wellness behaviors: diet high in fruits & vegetables & low in meats, 
taking antioxidants, vitamin D importance, lifestyle factors, & exercise   
(Maloni, H., 2018). 
• Educate MS patients on disease modifying therapies (DMT); several available 
making options complex.
• FNPs teach & be sure patients understand short & long-term side effects, treatment 
guidelines, & treatment monitoring to maximize success. 
• Set realistic expectations, MS is not curable, treatments intended to slow disease 
progression & limit disease activity.
• FNPs monitor & manage side effects of DMTs 
(Roman, C., & Menning, K, 2017)
References
Underlying 
Pathophysiology
• Greatest risk: Infectious 
mononucleosis during early adulthood
• Exposure to the Epson-Barr virus 
(EBV) (present in 90% of the general 
population, 30-40% of those will 
develop infectious mononucleosis) 
Reactivation of EBV has a positive 
correlation with relapses
• Smoking ⟶Worse disease 
progression & worse MRI outcomes 
• Vitamin D deficiency ⟶ hypothesized 
to increase risk of developing MS, 
causing worse outcomes & higher 
occurrence of relapses 
• MS occurs in higher rates in areas 
further from the equator 
(Guan et al, 2019).
• The gut microbiome & dietary patterns 
• Genetic susceptibility
(Grigoriadisa, N., & Van Pesch, V., 2015)
• The Hygiene Hypothesis: Areas with 
better hygiene & sanitation result in 
youth exposed to less pathogens 
leading to higher rates of autoimmune 
diseases (Guan et al, 2019).  
Family nurse practitioners (FNP) in northern United States may encounter MS often 
(Guan et al, 2019).  
MS patients need a well-coordinated team of professionals with shared decision 
making to diagnose and treat symptoms of MS successfully and improve or 
maintain quality of life. 
FNP role is important in assisting with diagnosis & life-time management: 
• Screen for & manage symptoms
• Ask the right questions to discover compensatory behavior & strategize with the 
patient on ways to improve quality of life:
• Everyday life ?s: problems with driving, cooking, following a recipe, 
participating in a group activity. 
• Look at underlying conditions that could be causing cognitive impairment
• The Symbol Digit Modalities Test = quick, cost-effective screening for cognitive 
impairment
• Symptom treatment, interpret lab results, communicate diagnosis, referrals for 
cognitive rehabilitation & neurologists
Neurologic diseases are often difficult to 
comprehend since the Neurosystem is 
very complex.  Multiple Sclerosis (MS) is 
among one of the many neurologic 
diseases in which there is no cure and it 
is unknown why exactly it develops.  
According to Khorramdelazad, H., 
Bagheri, V., Hassanshahi, G., Zeinali, M., & 
Vakilian, A. (2016), MS “is the main cause 
of nontraumatic neurological disability in 
young adults” (p. 72).  MS is a chronic 
autoimmune inflammatory disease 
resulting from inflammation of the 
central nervous system (CNS), blood-
brain-barrier (BBB) breakdown, and 
demyelination of the brain and spinal 
cord white matter leading to lesions and 
axonal damage affecting the CNS (Guan, 
Y., Jakimovski, D., Ramanathan, M., 
Weinstock-Guttman, B., & Zivadinov, R., 
2019).  This damage is followed by 
complete or partial recovery with scaring 
or sclerosis (McCance, K. L., & Huether, S. 
E. (eds.)., 2018).  Family Nurse 
Practitioners (FNP) and other healthcare 
professionals need to understand and 
assist with early treatment as well as 
manage lifelong treatment for the MS 
patient to maintain or improve quality of 
life. 
• “A diffuse and progressive CNS 
inflammatory autoimmune disease that 
affects white and gray matter” 
anywhere in the CNS (McCance, K. L., & 
Huether, S. E. (eds.)., 2018, p. 581).
• Adaptive & innate immunity involved 
⟶ inflammation from oxidative injury 
& mitochondrial dysfunction from 
oxidative free radicals in microglia & 
macrophages. Oxidative injury 
amplified with aging by microglia 
activation, progressive mitochondrial 
damage, & accumulation of iron in the 
CNS (Grigoriadisa, N., & Van Pesch, V., 
2015).  
• B cells, T cells, & macrophages breech 
BBB of the brain & spinal cord, 
“recognize myelin autoantigens and 
produce myelin-specific antibodies 
triggering inflammatory 
demyelination” (McCance, K. L., & 
Huether, S. E. (eds.)., 2018, p. 581). 
• Leads to loss of oligodendrocytes & 
myelin sheaths ⟶ disrupt nerve 
connections (McCance, K. L., & Huether, 
S. E. (eds.)., 2018).
• TH1 & TH17 pro-inflammatory 
lymphocytes activated in periphery, 
cross the BBB, penetrate the CNS & are 
reactivated by CNS antigens inducing 
an inflammatory response inducing 
macrophage & microglial activation 
creating more pro-inflammatory 
mediators, oxygen, & nitric oxide 
radicals causing demyelination & 
axonal loss (Grigoriadisa, N., & Van 
Pesch, V., 2015). 
• Relative preservation of axons & glial 
or astrocytic scar formation 
• Relapse = at least partial repair
• Progressive forms can lead to death of 
neurons and brain atrophy 
(McCance, K. L., & Huether, S. E. (eds.)., 
2018
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Multiple sclerosis is a debilitating 
autoimmune disease characterized by 
inflammation, demyelination, and 
damage to nerves with or without 
relapse.  The exact pathology is 
unknown, but many theories include 
cells of the innate and adaptive immune 
system crossing over the BBB and 
initiating damaging inflammation.  
Infection by EBV and alteration of the 
CXCL12 gene are two theories in the 
pathophysiology and development of MS.  
The pathophysiology is important for the 
development of new treatments, possible 
vaccination, and a possible cure 
someday.  The FNP has an important role 
of screening patients, making referrals to 
correct medical providers, educating and 
advocating for the patient, and 
monitoring and managing symptoms 
throughout the MS patients life.
Conclusion
Early diagnosis & initiation of treatment 
is important!
• Get inflammation under control to 
decrease the amount of damage, 
preventing permanent disability 
• Discovering the exact pathology of MS 
will assist in new treatments & maybe 
someday a cure 
• Main therapies are focusing on antigen 
presentation, peripheral immune 
response, the BBB, & target tissue in 
the CNS 
(Grigoriadisa, N., & Van Pesch, V., 
2015)
• CXCR4 & CXCL12 currently being 
researched as a therapeutic target for 
several systematic autoimmune & 
neuroinflammatory diseases, such as 
MS. Serum levels of CXCL12 have 
potential to be used as a MS prognosis 
biomarker. Increased levels may 
correlate with increased levels of 
autoimmunity
(Khorramdelazad et al, 2016)
• Research for EBV vaccination, not 
successful currently (Guan et al, 
2019).  
Significance of 
Pathophysiology
A 24-year-old Caucasian female visits a Columbus, Ohio clinic with complaints of blurry 
vision in her right eye that started two days ago.  She states she is tired all the time and has 
been having “weird things” occurring to her for the past several years, such as the inability 
to concentrate, trouble following simple instructions at times, sharp pains shooting through 
her right arm at random, and being unstable on her feet occasionally.  Her symptoms have 
always resolved and she states she “always contributed it to stress.”
She has a history of infectious mononucleosis as a teenager.  
Physical examination reveals right-hand grasp is slightly weaker than left, nystagmus of the 
right eye, and some pain with eye movement. 
She is afebrile, vital signs are normal, no findings of any infection
She is referred to a neurologist and a brain MRI is ordered, which reveals a diagnosis of MS
Multiple Sclerosis Case
Human CXCL12 gene and cytokine:
• may be responsible for causing 
inflammation, remyelination, & 
neuroprotection
• Facilitate leukocyte recruitment & 
migration into the CNS
• Important for developmental 
processes such as hematopoiesis, 
cardiogenesis, vascular formation, 
neurogenesis
• Alterations in CXCL12 gene 
expression, located on chromosome 
10, recruits & facilitates CXCR4-
expressing mononuclear cells 
across BBB leading to progression 
& development of MS 
• Active and silent lesions have 
CXCL12 present
(Khorramdelazad et al, 2016).
• Axonal transection & damage: 
Linked to brain atrophy in MS at a 
rate of 0.5-1% per year correlates 
with physical & cognitive disability 
(Grigoriadisa, N., & Van Pesch, V., 
2015)
Introduction
Symptom subtype 
of MS
Symptoms Area of Impact
Relapsing-
Remitting
Most common 
Recurring exacerbations of 
previous symptoms with acute 
axonal loss followed by complete 
or partial recovery that lasts 
days to months (Guan et al, 
2019). 
Dominated by multifocal 
inflammatory demyelinated 
plaques in white matter 
(Grigoriadisa, N., & Van Pesch, 
V., 2015).
Primary 
Progressive
Least Common
Gradual progression & 
continuously accumulating 
physical disability without 
relapse (Guan et al, 2019). 
Most prevalent in the spinal 
cord with gradual loss of power 
in lower limbs, asymmetric, 
bowel & bladder problems 
(McCance, K. L., & Huether, S. E. 
(eds.)., 2018).
Secondary 
Progressive
• Relapsing-remitting evolve 
into progressive disease 
with worsening disability 
with or without relapses 
(Guan et al, 2019
• Relapses get shorter in 
duration & symptoms 
progressively more severe 
(McCance, K. L., & Huether, 
S. E. (eds.)., 2018).
Inflammation 
compartmentalized in the CNS 
“characterized by the presence 
of ectopic lymphoid follicles 
particularly in the meninges” 
(Grigoriadisa, N., & Van Pesch, 
V., 2015, p.8). 
Progressive 
Relapsing 
“Steadily worsening symptoms from the onset with clear acute 
relapses but often with more severe symptoms” (McCance, K. L., & 
Huether, S. E. (eds.)., 2018, p. 582). 
• Onset between 20-40 years; life 
expectancy not greatly altered
• More common in females 
• Males may have more severe 
progressive course 
• First demyelinating event: commonly a 
single neurologic dysfunction lasting 
longer than 24 hours without fever, 
infection, or encephalopathy. 
• Multifocal: Paresthesia of the face, 
trunk, or limbs, weakness, impaired 
gait, visual disturbances, urinary 
incontinence, optic neuritis most 
commonly in one eye with progressive 
blurring & pain 
• Spinal cord syndrome: in sensory or 
motor tracks starting on one side of the 
body & progressing to the other, 
• Brainstem syndromes: facial sensory 
loss or weakness, vertigo, or double 
vision. 
• Cerebellar syndromes: lack of 
coordination, tremor, gait instability, 
ataxia. 
• Cerebrum symptoms: hemifacial 
weakness, pain, motor impairments. 
• Cognitive impairments: occur later in 
disease: memory & attention problems 
as well as Psychiatric disorders, 
depression, dementia 
(McCance, K. L., & Huether, S. E. (eds.)., 
2018). 
• Characterized by flare-ups or attacks of 
symptoms that can last from days to 
weeks. Can either resolve or become 
permanent (Khorramdelazad et al, 
2016). 
• 70% of MS patients experience 
cognitive impairment from mild 
forgetfulness to mild to moderate 
dementia (Maloni, H., 2018)
Epson-Barr Virus and the Two-Hit Hypothesis Pathophysiology of MS:
• Memory B cells (antigen presenting cells) act as reservoirs for EBV & are 
thought to enhance BBB permeability allowing pre-existing polyclonal antibody-
producing B cells to enter the CNS 
• Memory B cells activate auto-aggressive T-cells against myelin proteins
• High levels of CD40 on B cells suggest a higher level of antigen presentation of 
EBV; associated with higher levels of neurodegeneration & found in actively 
demyelinating lesions
• EBV immortalizes Memory B cells interacting with tumor suppressor genes ⟶
become undetectable to T-cell surveillance 
(Guan et al, 2019).  
• Acute axonal damage has been correlated with CD8+ T cells, pro-inflammatory 
mediators with cytologic activity against EBV, found in the brain & cerebral 
spinal fluid (Grigoriadisa, N., & Van Pesch, V., 2015) 
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MRI is the most sensitive tool to diagnose & monitor 
MS (Guan et al, 2019).  These photos are MRIs of 
patients with MS. Macrophages & microglial cells 
have been found in active MS lesions” (McCance, K. 
L., & Huether, S. E. (eds.)., 2018).
